Does noninvasive monitoring of peak filling rate with acoustic quantification echocardiography accurately detect acute cardiac allograft rejection?
We conclude that diastolic dysfunction during acute cardiac allograft rejection can be accurately detected by noninvasive measurement of peak filling rate with acoustic quantification echocardiography. Monitoring of this parameter provides reliable discrimination between treatable and nontreatable rejection.
Neonatal HC therapy has fewer short- and long-term adverse effects than neonatal DEX therapy.